NIKE, Inc.

There is a swoosh on this page you recognised before you read a word of it — and that recognition, repeated across seven billion people, is the business. Nike designs shoes and clothing, has almost all of it made by contractors in Vietnam and Indonesia, and sells it at a premium the world pays because of what the logo means. For fifty years that was one of the great money-machines in consumer history. Today the stock trades at $44.57, roughly 75% below its 2021 peak of ~$179, at a decade low — and the question this report must answer is the oldest one in value investing, and the one on which Warren Buffett made his single worst mistake: is a shoe brand a durable moat, or a fashion cycle wearing the costume of one?

The numbers show a wounded giant, not a broken one. In the fiscal year ended May 2026, Nike earned $3.1 billion on $46.4 billion of revenue — but note the trajectory: revenue is down ~$5B from its FY2024 peak, and profit has been halved from the ~$6 billion it earned in FY2022. Operating margins have fallen from 16% to 8%. This is a company that lost its way — first through a strategic blunder (Part II), then to a wave of nimble upstarts (Part V) — and is now, under a returning insider, trying to find it again. The dividend, tellingly, has been raised for 24 straight years and now yields ~3.7%, the highest in Nike's modern history — a statistic that tells the valuation story by itself.

"If any of my competitors were drowning, I'd stick a hose in their mouth and turn on the water." — Phil Knight, Nike founder

That was the DNA that built Nike from shoes sold out of the trunk of a Plymouth Valiant into a $65 billion company. The uncomfortable truth of the last five years is that Nike was the one with the hose in its mouth — its own management handed rivals the shelf space, the running category, and the innovation crown. Whether the founder's competitive fire can be rekindled by the man now running the company is the entire turnaround bet. But first, an owner must decide the deeper question — whether the brand underneath the mess is Coca-Cola or a fad — because that, not the turnaround, determines what a share is worth.

Nike's history is the best founding myth in business — and its recent chapter is a textbook of how a great company wounds itself. Both halves matter to an owner.

The lesson an owner must extract is precise. Nike's collapse was not caused by a competitor out-innovating it or by the brand suddenly dying — it was caused by a management strategy that mistook the fashion layer for the moat layer. Donahoe cut the wholesale doors that put Nikes in front of casual buyers, starved the sport-innovation engine, and flooded the market with retro Dunks and Air Jordans until they became discount-bin commodities. The good news in that diagnosis: a self-inflicted wound can, in principle, be self-healed, and the man now healing it spent 32 years learning where the bodies are buried. The bad news: while Nike was distracted, a pack of upstarts drove a road straight through the moat (Part V) — and roads, once built, are hard to close.

Before the machine, the ghost — because it hangs over this entire analysis. In 1993 Warren Buffett bought Dexter Shoe, paying with Berkshire stock, and praised its "durable competitive advantage." Cheap imports destroyed it within a decade. His 2007 verdict: "the worst deal that I've made." By his 2014 letter, the Berkshire shares he'd handed over had grown to ~$5.7 billion — "a financial disaster deserving a spot in the Guinness Book of World Records." The lesson Buffett drew was brutal and specific: in footwear, cost curves and fashion cycles can dissolve what looks like a moat. Any analysis of Nike must pass through that graveyard.

Here is the honest split, and it is the crux of the whole report. Buffett's great consumer champions — Coca-Cola, See's, Gillette — sell repeat-purchase consumables with near-zero fashion risk: you buy the same Coke your father did. Sneakers are semi-durable, taste-driven, and fashion-inflected — closer to apparel retail, the category where Buffett has repeatedly been burned. So the swoosh sits exactly on the fault line between his best idea (unbreachable consumer brands) and his worst confession (shoes). My own read, which the rest of this report will test: the swoosh itself has See's-like durability — it survived the 1990s sweatshop crisis, multiple management fumbles, and 50 years of would-be killers — but individual franchises (the Dunk, the Air Jordan retro) are pure Dexter-like fashion, and the fatal 2020–24 error was running the fashion layer as if it were the moat. The question for today's buyer is whether the durable core is intact beneath the fashionable rot.

FY2026 revenue, by what it sells and where:

The channel story is the turnaround in miniature. Donahoe's strategy pushed Nike toward selling direct — its own stores and nike.com — and away from wholesale partners, on the theory that direct sales carry fatter margins. It backfired twice: the vacated wholesale shelves were filled by On, Hoka and New Balance, and the direct economics proved worse than promised once discounting and returns were counted. Hill is deliberately reversing it: FY2026 wholesale grew ~6% (back on Amazon and Foot Locker's shelves) while Nike's own direct channel shrank by design, repositioned as a full-price showcase rather than a discount outlet. And the China line is the single hardest part of the whole story — a market that was once Nike's profit jewel is now a nationalistic, discount-heavy fight where local champions Anta and Li-Ning are approaching Nike's share for the first time. A recovery that works everywhere except China would still be a diminished Nike.

Nike's moat is genuine but — like Alphabet's and Novo's — contested for the first time in a generation, and here the erosion is unusually visible in the numbers. Three walls:

1 · The brand. Still the most valuable (or strongest) apparel brand on Earth by most rankings — a value variously estimated at $31–50 billion depending on methodology. Nike's ~$46B of revenue is roughly double Adidas and five times Puma. This wall is real and, at the brand level, has proven durable across 50 years. Trend: intact but dented.

2 · The athlete book. $16.2 billion of endorsement obligations — Jordan (in perpetuity), LeBron and Ronaldo (lifetime deals), the NBA and NFL. This is a contractual moat On, Hoka and New Balance combined could not fund. Trend: stable — the one wall competitors truly cannot climb.

3 · Scale in sponsorship and supply. ~500 million pairs a year, the biggest marketing budget in sport, and — the double edge — a China-heavy Asian supply chain that tariffs turned from pure asset into partial liability. Trend: stable, tariff-exposed.

Where it cracks — the numbers are stark. While Nike shrank, the upstarts ran: New Balance did $9.2B in 2025, up 19% — its fifth straight year of double-digit growth, explicitly "taking share from Nike." On grew ~28–43% and — the detail that should alarm any Nike bull — commands a ~$143 average selling price in running versus Nike's ~$83. In the one category Nike invented and once owned, a Swiss upstart now has the pricing power. Hoka pushed Deckers to a record year. In China, Anta approaches Nike's share. This is not a brand dying — Nike still leads by a mile in absolute size — but it is a moat with a toll-free bypass road that the competition built while management was distracted, and roads are hard to close. There is a real counter-signal worth its weight: by late 2025–26, run-specialty retailers reported Nike's running business rebounding (the Vomero 18 became a $100M franchise in months) even as Hoka slowed. I score the moat a 6: a genuinely strong brand, with a genuinely open flank.

The entire equity case above the dividend rests on whether one man can rebuild what another broke. Elliott Hill is the right archetype: he joined Nike as a sales intern in 1988, spent 32 years rising to run the marketplace, retired when passed over for CEO in 2020, and was called back in October 2024 to fix the mess. He is the wholesale relationships he is rebuilding — retail CEOs publicly welcomed him back. His 'Win Now' plan is coherent, and the pieces are executing:

The honest verdict, in the company's own words: not yet. The structural fixes are real — wholesale is growing, running is recovering, inventory is clean — but total revenue is still shrinking currency-neutral, China is still falling, Converse is in free-fall (−31%, a possible write-down), and Hill has now twice pushed the payoff date, telling investors in June 2026 that the full impact "won't show until next year" and, memorably, that "we are building like the New York Knicks" — unglamorous, patient, rebuilding. The market has stopped believing promises and now trades only on sell-through. That is the correct posture for an owner, too: this is a "prove it" turnaround, credible but unproven, and the burden of proof sits with the FY2027 numbers, not the FY2026 narrative.

Read the table the right way. In absolute scale, Nike is still the colossus — bigger than Adidas and Puma combined, with an athlete roster no one can approach. But the pattern of the last five years is unmistakable: Nike lost ground everywhere a focused competitor showed up — pricing power to On in running, the lifestyle crown to Adidas's Samba, women's to Lululemon, China to Anta. None of these is fatal individually; collectively they are the signature of a moat that was left undefended. The bull's case is that these are cyclical — Adidas already frets about "Samba fatigue," Hoka is slowing, and Nike's running rebound is real. The bear's case is that On's $143 shoe proves the premium has permanently migrated. Which it is — cycle or structural share loss — is the same See's-versus-Dexter question in a different suit.

Management is credible; the ownership structure means you back it or you don't — you cannot force it.

Capital allocation — the good and a real scar. The good: a 24th consecutive annual dividend increase (Nov 2025), raised even through the collapse, now yielding ~3.7% — one more raise (Nov 2026) makes Nike a Dividend Aristocrat, a milestone it may clinch in the same year it hit a decade low. The scar: Nike spent $12.1 billion of a buyback authorisation at an average price of ~$97.57 — more than double today's $45 — then paused repurchases in FY2026 when the cash flow tightened. That is the textbook error Buffett warns against: buying your own stock aggressively when it is expensive and stopping when it is cheap. It cost shareholders billions and it constrains the buyback firepower precisely now, when it would do the most good. On the strength of the dividend discipline but the weight of that timing error and the Donahoe strategic blunder that happened on this board's watch, I score management a 6. One reassuring note: with FY2026 dividends (~$2.4B) now running close to free cash flow (~$2.2B), the payout is covered but no longer comfortably — the ~3.7% yield is safe, but its growth will be modest until earnings recover.

One asterisk you must not miss: FY2026's reported EPS of $2.10 was flattered by a one-time item — a ~$0.52-per-share benefit from the recovery of nearly $1 billion of tariffs that were struck down in court. Strip it out and the underlying earnings power is closer to $1.58, which is why analyst estimates put FY2026–27 EPS at just ~$1.50–1.74 before a projected recovery toward ~$2.20 (FY2028) and ~$4.25 (FY2030). That gap between the flattered headline and the true run-rate is the whole valuation question. The reassurance is the balance sheet: $9 billion of cash, net debt under one turn of EBITDA, an Altman-Z of 3.6. Whatever else is true, Nike is in no financial danger — it has the fortress to fund a multi-year turnaround and keep raising the dividend while it waits. This is a company that can afford to be patient. The question is whether its owners can, and whether the patience pays.

This is the hardest kind of stock to value, because the right number depends entirely on which earnings you believe. On today's depressed earnings, Nike is expensive — 21× a flattered $2.10, ~30× the ~$1.74 the business will likely earn next year. On normalized earnings — a recovery to even a 12% operating margin, well below its own history, on roughly today's revenue — Nike earns close to $3.50–4.00 a share, and the stock trades at ~11–12×, which for the world's #1 sports brand would be genuinely cheap. The automated DCF lands at $51 (+14%) and Wall Street's average target at $52.53 (+18%) — both modest, both saying: fair value is somewhat higher, but no one is pricing a full recovery. That is the honest picture — a real but modest margin of safety, backstopped by a ~3.7% yield that pays you to wait and a fortress balance sheet that guarantees you can wait. It is not the +73% of Novo Nordisk; it is a narrower, patience-dependent value. The zone deepens toward the ~$40 52-week low, where the yield pushes past 4% and you are buying the #1 brand for the price of a struggling one.